Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other Working Capital Changes (2016 - 2025)

Apyx Medical's Other Working Capital Changes history spans 15 years, with the latest figure at -$228000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 27.62% year-over-year to -$228000.0; the TTM value through Dec 2025 reached -$237000.0, up 72.35%, while the annual FY2025 figure was -$237000.0, 72.35% up from the prior year.
  • Other Working Capital Changes reached -$228000.0 in Q4 2025 per APYX's latest filing, down from $425000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.5 million in Q2 2021 to a low of -$1.4 million in Q4 2021.
  • Average Other Working Capital Changes over 5 years is -$86900.0, with a median of -$234500.0 recorded in 2024.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 5351.85% in 2021, then tumbled 25600.0% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$1.4 million in 2021, then soared by 100.15% to $2000.0 in 2022, then crashed by 25600.0% to -$510000.0 in 2023, then soared by 38.24% to -$315000.0 in 2024, then increased by 27.62% to -$228000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Other Working Capital Changes are -$228000.0 (Q4 2025), $425000.0 (Q3 2025), and -$397000.0 (Q2 2025).